Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02990598 · ClinicalTrials.gov registry record
Hydoxyurea Exposure in Lactation A Pharmacokinetics Study (HELPS)
A clinical trial, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- 16
- Enrollment target
NCT02990598: Completed study, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT02990598 is a clinical trial that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02990598 has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
To examine the pharmacokinetics and distribution of oral hydroxyurea when administered as a single dose to lactating women
Primary Outcome
Hydroxyurea concentration for each collected specimen will be analyzed and summarized.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2017-03-20 |
| Est. Completion | 2018-06-19 |
What the finished NCT02990598 record still lists
NCT02990598 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02990598 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02990598 about?
NCT02990598 is a clinical study titled "Hydoxyurea Exposure in Lactation A Pharmacokinetics Study (HELPS)". To examine the pharmacokinetics and distribution of oral hydroxyurea when administered as a single dose to lactating women
What is the current status of trial NCT02990598?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2017-03-20. Estimated completion is 2018-06-19.
Who is sponsoring clinical trial NCT02990598?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI